The clinical implications of increased coexpression of CD40-CD40 ligand system and C-reactive protein in patients after percutaneous coronary intervention

Clinica Chimica Acta

Volumn 374, Issue 1-2, 2006, Pages 140-141

  Yan, Jin Chuan ^a   Ma, Gen Shan ^b   Zhu, Jian ^b   Feng, Yi ^b   Luo, Dan ^b   Wu, Zong Gui ^c   KingG, Xian Tao ^c   Zong, Ren Qian ^c   Zhan, Lin Zen ^c  

^a JIANGSU UNIVERSITY   (China)

^b SOUTHEAST UNIVERSITY   (China)

^c SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 ANTIGEN; CD40 LIGAND;

ARTERY DIAMETER; ATHEROSCLEROSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RESTENOSIS; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON, CORONARY; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ANTIGENS, CD40; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CORONARY RESTENOSIS; HUMANS; LIGANDS; PREDICTIVE VALUE OF TESTS; UP-REGULATION;

EID: 33750007427     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2006.05.025     Document Type: Letter

References (9)

1. Phipps R.P. Atherosclerosis: the emerging role of inflammation and the CD40-CD40 ligand system. Proc Natl Acad Sci U S A 97 (2000) 6930-6932
2. Aukrust P., Muller F., Ueland Thor B.S., et al. Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Circulation 100 (1999) 614-620
3. Yan J.C., Wu Z.G., Li L., Zhong R.Q., and Kong X.T. The clinical implications of increased expression of CD40 L in patients with acute coronary syndromes. Chin Med J 115 (2002) 491-493
4. Yan J.C., Wu Z.G., Kong X.T., Zhong R.Q., and Zhan L.Z. Relation between upregulation of CD40-CD40 ligand system and serum levels of matrix metalloproteinases and complex stenosis morphology in patients with acute coronary syndrome. Acta Pharm Sin 25 (2004) 251-256
5. Cipollone F., Marini M., Fazia M., et al. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21 (2001) 327-334
6. Yan J.C., Wu Z.G., Chen J.M., Li L., and Kong X.T. Upregulation of CD40-CD40L ligand system in patients with diabetes mellitus. Clin Chim Acta 339 (2004) 85-90
7. Yan J.C., Zhu J., Gao L., Ma G.S., Wu Z.G., and Kong X.T. The effect of elevated serum soluble CD40 ligand on the prognostic value in patients with acute coronary syndromes. Clin Chim Acta 343 (2004) 155-159
8. Michelson A.D., Barnard M.R., Krueger L.A., Frelinger III A.L., and Furman. Evaluation of platelet function by flow cytometry. Methods 21 (2000) 259-270
9. Azar R.R., Mckay R.G., Kiernan F.J., et al. Coronary angioplasty induces a systemic inflammatory response. Am J Cardiol 80 (1997) 1476-1478